Brussels Regulatory Conference Organized in partnership between ECCA & ECPA

Crop Protection

European Regulatory Conference

15th-16th March 2017

Hotel Le Plaza

Boulevard Adolphe Max 118

B-1000 Brussels

Organized in partnership between ECCA & ECPA

Day 1: Wednesday 15th March
Conference workshops
Workshop 1 (10h15 – 11h30)
Market & communications / Workshop 2 (09h10 – 11h30)
Regulatory issues
Registration
09h00: Introduction
Chairman: tbc / 09h00: Introduction
Chairman: Hans Mattaar, ECCA
09h15: Speaker tbc – Comitology rules and impact on EU decisions / 09h15: Ingrid Langer, AGES - Harmonized dose expression in 3D crops and other efficacy challenges
09h35: Speaker tbc: Update on recent legal cases / 09h35: Beth Hall, Syngenta - Industry view: Key efficacy challenges in zonal system
10h00: Q&A / 09h55: Q&A
10h10: Matthew Phillips, PhillipsMcDougall - Market update / 10h10: Chris Dobe, Syngenta - Update on co-formulants
10h30: David Cary, IBMA - Low risk substances: An opportunity?
10h45 Graeme Taylor, ECPA – Benefits campaign
10h50: Jeroen Meeussen, Minor Use Coordination Facility - Minor use developments
11h15: Panel discussion / 11h10: Panel discussion
11h30 / Coffee
Introductory session
Chairman: Hans Mattaar, ECCA
11h50 / Jean-Philippe Azoulay, ECPA Director General: Welcome address
12h00 / Wolfgang Reinert - Update on implementation of Regulation 1107/2009
12h30 / Martyn Griffiths, Bayer - Regulation 1107/2009 - challenges for today and the future
13h20 / Question and answer
13h30 / Lunch
Active substance evaluation update
14h30 / Mark Williams, DG SANTE - AS review programme
14h55 / Benedicte Vagenende, EFSA - EFSA update on active substances review
15h20 / Luuk van Duijn, Ctgb - MS challenges in AS review - can we improve?
15h45 / Panel discussion
16h15 / Coffee
Developments in human health risk assessment
16h45 / Carole Langrand-Lerche, Bayer - Regulatory challenges in human health RA
17h10 / Roland Solecki, BfR - Member State view on challenges in human health RA
17h35 / Speaker tbc – Impact of active substance conclusions on product re-registration
18h00 / Jarlath Hynes, HSi - Opportunities for efficient testing strategies
18h15 / Panel discussion
18h30 / Cocktail reception
Sponsored by: /
20h00 / Conference dinner
Sponsored by: /
Day 2: Thursday 16th March
Update on Endocrine disruption and classification issues
08h20 / Welcome
08h30 / Karin Nienstedt, DG SANTE - Endocrine disruption and guidance update
08h55 / Jean-Pierre Busnardo, DuPont – Industry view on Endocrine disruption
09h20 / Jonas Nygren - Overview of the CLH process, emerging challenges and specific issues in the classification of pesticide active substances
09h40 / Panel discussion
10h00 / Coffee
Product evaluation challenges
10h30 / Dara O'Shea, DG SANTE – Evaluating the implementation of Regulation 1107/2009
10h55 / Darren Flynn, CRD - Zonal system and (inter)zonal cooperation
11h15 / Chrstian Prohaska, AGES - Article 43 - where's the silver bullet?
11h40 / J-L Alonso-Prados, INIA - South zone challenges
12h05 / Jeanne Roederer, Adama - Industry view on key challenges in product authorisation
12h25 / Panel discussion
12h45 / Lunch
Legislative review
13h45 / Hans Mattaar, ECCA – Introduction to a discussion on the review of 1107 & 396
14h00 / Pierre Petelle, CropLife Canada - Data call-in system - what can we learn from Canada?
14h25 / Johan Axelman, Sweden - Can we streamline the EU evaluation process for PPPs?
14h50 / Kees Romijn, Bayer – The role of protection goals to support the EU regulatory process
15h00 / Panel discussion
15h30 / Conclusions
15h45 / Close